Surveillance of Vaccination Coverage among Adult Populations — United States, 2015

CDC, 2010, Estimates of deaths associated with seasonal influenza—United States, 1976–2007., MMWR Morb Mortal Wkly Rep, 59, 1057

Thompson, 2004, Influenza-associated hospitalizations in the United States., JAMA, 292, 1333, 10.1001/jama.292.11.1333

Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Morb Mortal Wkly Rep, 63, 822

Yawn, 2007, A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction., Mayo Clin Proc, 82, 1341, 10.4065/82.11.1341

Williams WW, Lu P-J, O’Halloran AO, Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveill Summ 2016;65(No. SS-1).

CDC, 2017;, Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years and older—United States, 2017., MMWR Morb Mortal Wkly Rep

CDC. Flu vaccination coverage, United States, 2015–16 influenza season. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/flu/fluvaxview/coverage-1516estimates.htm

Black, 2015, Influenza vaccination coverage among health care personnel—United States, 2014–15 influenza season., MMWR Morb Mortal Wkly Rep, 64, 993, 10.15585/mmwr.mm6436a1

Ding H, Black CL, Ball S, Flu vaccination among pregnant women—United States, 2015–16 flu season. Atlanta, GA: US Department of Health and Human Services, CDC; 2016.https://www.cdc.gov/flu/fluvaxview/pregnant-coverage_1516estimates.htm

CDC, 2013, Surveillance of influenza vaccination coverage—United States, 2007–08 through 2011–12 influenza seasons., MMWR Surveill Summ, 62

CDC), 2013, Estimated influenza illnesses and hospitalizations averted by influenza vaccination—United States, 2012–13 influenza season., MMWR Morb Mortal Wkly Rep, 62, 997

Reed, 2014, Estimated influenza illnesses and hospitalizations averted by vaccination—United States, 2013–14 influenza season., MMWR Morb Mortal Wkly Rep, 63, 1151

13. Community Preventive Services Task Force. The guide to community preventive services. Vaccination—Task Force findings. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.thecommunityguide.org

National Vaccine Advisory Committee, 2014, Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice., Public Health Rep, 129, 115, 10.1177/003335491412900203

Black, 2015, Influenza vaccination coverage among health care personnel—United States, 2014–15 influenza season., MMWR Morb Mortal Wkly Rep, 64, 993, 10.15585/mmwr.mm6436a1

Black, 2014, Influenza vaccination coverage among health care personnel—United States, 2013–14 influenza season., MMWR Morb Mortal Wkly Rep, 63, 805

Black, 2016, Influenza vaccination coverage among health care personnel—United States, 2015–16 influenza season., MMWR Morb Mortal Wkly Rep, 65, 1026, 10.15585/mmwr.mm6538a2

Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Morb Mortal Wkly Rep, 63, 822

CDC, 2012, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Morb Mortal Wkly Rep, 61, 816

Kobayashi, 2015, Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Morb Mortal Wkly Rep, 64, 944, 10.15585/mmwr.mm6434a4

CDC, 2012, Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older—Advisory Committee on Immunization Practices (ACIP), 2012., MMWR Morb Mortal Wkly Rep, 61, 468

Sheridan, 2014, Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology., Expert Rev Vaccines, 13, 1081, 10.1586/14760584.2014.944167

Koepke, 2014, Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand., J Infect Dis, 210, 942, 10.1093/infdis/jiu322

Skoff, 2016, Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity–a follow-up analysis., JAMA Pediatr, 170, 453, 10.1001/jamapediatrics.2015.4875

Suryadevara, 2015, Prevention of pertussis through adult vaccination., Hum Vaccin Immunother, 11, 1744, 10.1080/21645515.2015.1038442

Wendelboe, 2005, Duration of immunity against pertussis after natural infection or vaccination., Pediatr Infect Dis J, 24, S58, 10.1097/01.inf.0000160914.59160.41

Magpantay, 2016, Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity., Parasitology, 143, 835, 10.1017/S0031182015000979

CDC. Long-term effectiveness of whooping cough vaccines. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/pertussis/pregnant/mom/vacc-effectiveness.html

Liko, 2013, Priming with whole-cell versus acellular pertussis vaccine., N Engl J Med, 368, 581, 10.1056/NEJMc1212006

Klein, 2013, Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers., Pediatrics, 131, e1716, 10.1542/peds.2012-3836

CDC, 2013, Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012., MMWR Morb Mortal Wkly Rep, 62, 131

United States Government Accountability Office. Report to Congressional Committees. Medicare—many factors, including administrative challenges, affect access to Part D vaccinations. GAO-12-61. December 2011. http://www.gao.gov/products/GAO-12-61

Hurley, 2010, Barriers to the use of herpes zoster vaccine., Ann Intern Med, 152, 555, 10.7326/0003-4819-152-9-201005040-00005

Joon Lee, 2013, Herpes zoster knowledge, prevalence, and vaccination rate by race., J Am Board Fam Med, 26, 45, 10.3122/jabfm.2013.01.120154

Harpaz, 2008, Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Recomm Rep, 57, 1

Berkowitz, 2015, Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study., J Infect Dis, 211, 1279, 10.1093/infdis/jiu606

Stadtmauer, 2014, A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients., Blood, 124, 2921, 10.1182/blood-2014-04-573048

Lal, 2013, Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults., Hum Vaccin Immunother, 9, 1425, 10.4161/hv.24269

Mullane, 2013, Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults., J Infect Dis, 208, 1375, 10.1093/infdis/jit344

Chlibek, 2016, Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults., Vaccine, 34, 863, 10.1016/j.vaccine.2015.09.073

Lal, 2015, Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults., N Engl J Med, 372, 2087, 10.1056/NEJMoa1501184

Cunningham, 2016, Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older., N Engl J Med, 375, 1019, 10.1056/NEJMoa1603800

Markowitz, 2014, Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)., MMWR Recomm Rep, 63

Petrosky, 2015, Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices., MMWR Morb Mortal Wkly Rep, 64, 300

2016, —

Hariri, 2011, Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006., J Infect Dis, 204, 566, 10.1093/infdis/jir341

Liu, 2016, Seroprevalence of 9 human papillomavirus types in the United States, 2005–2006., J Infect Dis, 213, 191, 10.1093/infdis/jiv403

Burger, 2015, Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway., J Infect Dis, 211, 206, 10.1093/infdis/jiu413

Chesson, 2015, The cost-effectiveness of human papillomavirus vaccine catch-up programs for women., J Infect Dis, 211, 172, 10.1093/infdis/jiu414

Elbasha, 2007, Model for assessing human papillomavirus vaccination strategies., Emerg Infect Dis, 13, 28, 10.3201/eid1301.060438

Jit, 2008, Economic evaluation of human papillomavirus vaccination in the United Kingdom., BMJ, 337, a769, 10.1136/bmj.a769

French, 2007, Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland., Br J Cancer, 96, 514, 10.1038/sj.bjc.6603575

Regan, 2007, Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia., Sex Health, 4, 147, 10.1071/SH07042

Dasbach, 2008, The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan., Asian Pac J Cancer Prev, 9, 459

Liu, 2016, Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China., BMC Cancer, 16, 164., 10.1186/s12885-016-2207-3

Hariri, 2013, Population impact of HPV vaccines: summary of early evidence., J Adolesc Health, 53, 679, 10.1016/j.jadohealth.2013.09.018

Fairley, 2009, Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women., Sex Transm Infect, 85, 499, 10.1136/sti.2009.037788

Tabrizi, 2012, Fall in human papillomavirus prevalence following a national vaccination program., J Infect Dis, 206, 1645, 10.1093/infdis/jis590

Drolet, 2015, Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis., Lancet Infect Dis, 15, 565, 10.1016/S1473-3099(14)71073-4

Chesson, 2011, The cost-effectiveness of male HPV vaccination in the United States., Vaccine, 29, 8443, 10.1016/j.vaccine.2011.07.096

Chesson H, Markowitz L. The cost effectiveness of quadrivalent human papillomavirus vaccination of females over age 12 years in the United States. In: Alary M, ed. Proceedings of the 19th conference of the International Society for STD Research (Quebec City, Canada); July 10–13, 2011; Bologna, Italy: Medimond, 2011:19–22.

Elbasha, 2008, A multi-type HPV transmission model., Bull Math Biol, 70, 2126, 10.1007/s11538-008-9338-x

Usher, 2008, Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model., Vaccine, 26, 5654, 10.1016/j.vaccine.2008.07.098

Kim, 2008, Health and economic implications of HPV vaccination in the United States., N Engl J Med, 359, 821, 10.1056/NEJMsa0707052

Dasbach, 2008, The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK., BJOG, 115, 947, 10.1111/j.1471-0528.2008.01743.x

Kulasingam, 2007, A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program., Sex Health, 4, 165, 10.1071/SH07043

Insinga, 2007, Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation., Vaccine, 26, 128, 10.1016/j.vaccine.2007.10.056

Viens, 2016, Human papillomavirus-associated cancers—United States, 2008–2012., MMWR Morb Mortal Wkly Rep, 65, 661, 10.15585/mmwr.mm6526a1

CDC, 2012, Human papillomavirus-associated cancers—United States, 2004–2008., MMWR Morb Mortal Wkly Rep, 61, 258

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016;137:e20151968. Doi: 10. 1542/peds.2015-1968 Epub 2016 Feb 22.

Flagg, 2013, Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination., Am J Public Health, 103, 1428, 10.2105/AJPH.2012.301182

Hariri S, Johnson ML, Bennett NM, Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States. Cancer 2015;121:2775-81. Doi: 10. 1002/cncr.29266

Garland SM, Kjaer SK, Muñoz N, Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis 2016;63:519–27. Doi: 10. 1093/cid/ciw354

Bollerup, 2016, . Significant reduction in the incidence of genital warts in young men 5 years into the Danish human papillomavirus vaccination program for girls and women., Sex Transm Dis, 43, 238, 10.1097/OLQ.0000000000000418

Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia–nationwide follow-up of young Danish women. J Natl Cancer Inst 2014;106:djt460. Doi: 10. 1093/jnci/djt460

Baldur-Felskov, 2014, Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program., Cancer Causes Control, 25, 915, 10.1007/s10552-014-0392-4

Blomberg, 2013, Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark., Clin Infect Dis, 57, 929, 10.1093/cid/cit436

Baandrup, 2013, Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program., Sex Transm Dis, 40, 130, 10.1097/OLQ.0b013e31827bd66b

Jeyarajah, 2016, Human papillomavirus vaccination coverage among girls before 13 years: a birth year cohort analysis of the National Immunization Survey–Teen, 2008–2013., Clin Pediatr (Phila), 55, 904, 10.1177/0009922815616245

Lu, 2015, Racial and ethnic disparities in vaccination coverage among adult populations in the U.S., Am J Prev Med, 49, S412, 10.1016/j.amepre.2015.03.005

Singleton, 2005, Influenza and pneumococcal vaccination of adults aged ≥ 65: racial/ethnic differences., Am J Prev Med, 29, 412, 10.1016/j.amepre.2005.08.012

Lindley, 2006, The role of attitudes in understanding disparities in adult influenza vaccination., Am J Prev Med, 31, 281, 10.1016/j.amepre.2006.06.025

Bach, 2004, Primary care physicians who treat blacks and whites., N Engl J Med, 351, 575, 10.1056/NEJMsa040609

Gemson, 1988, Differences in physician prevention practice patterns for white and minority patients., J Community Health, 13, 53, 10.1007/BF01321480

Schwartz, 2006, Racial similarities in response to standardized offer of influenza vaccination., J Gen Intern Med, 21, 346, 10.1111/j.1525-1497.2006.00401.x

Daniels, 2006, Acceptance of pneumococcal vaccine under standing orders by race and ethnicity., J Natl Med Assoc, 98, 1089

Humiston, 2011, Increasing inner-city adult influenza vaccination rates: a randomized controlled trial., Public Health Rep, 126, 39, 10.1177/00333549111260S206

Bridges, 2015, Meeting the challenges of immunizing adults., Am J Prev Med, 49, S455, 10.1016/j.amepre.2015.08.014

Joon Lee, 2013, Herpes zoster knowledge, prevalence, and vaccination rate by race., J Am Board Fam Med, 26, 45, 10.3122/jabfm.2013.01.120154

Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121(Suppl 2):S28–35. 10.1016/j.amjmed.2008.05.005

Armstrong, 2001, Barriers to influenza immunization in a low-income urban population., Am J Prev Med, 20, 21, 10.1016/S0749-3797(00)00263-4

Winston, 2006, Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003., J Am Geriatr Soc, 54, 303, 10.1111/j.1532-5415.2005.00585.x

National Foundation for Infectious Diseases. Call to action: adult vaccination saves lives. Bethesda, MD: National Foundation for Infectious Diseases; 2012. http://www.adultvaccination.org/resources/ cta-adult.pdf

Lu, 2015, Impact of health insurance status on vaccination coverage among adult populations., Am J Prev Med, 48, 647, 10.1016/j.amepre.2014.12.008

Stewart, 2014, Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States., Vaccine, 32, 618, 10.1016/j.vaccine.2013.11.050

Hurley, 2014, U.S. physicians’ perspective of adult vaccine delivery., Ann Intern Med, 160, 161, 10.7326/M13-2332

Cutrona, 2016, Improving rates of influenza vaccination through electronic health record portal messages, interactive voice recognition calls and patient-enabled electronic health record updates: protocol for a randomized controlled trial., JMIR Res Protoc, 5, e56, 10.2196/resprot.5478

Shultz, 2015, A systems approach to improving Tdap immunization within 5 community-based family practice settings: working differently (and better) by transforming the structure and process of care., Am J Public Health, 105, 1990, 10.2105/AJPH.2015.302739

Powelson J. Learnings from a 7-group/6-state adult immunization collaborative, amid a shift from “volume to vale.” American Medical Group Association. National Adult and Influenza Immunization Summit; May 10, 2016; Atlanta, GA. https://www.izsummitpartners.org/summit/2016-naiis

Johnson C. Successful use of population analytics to increase immunization in a learning collaborative. American Medical Group Association. National Adult and Influenza Immunization Summit; May 10, 2016; Atlanta, GA. https://www.izsummitpartners.org/summit/2016-naiis

Wallis, 2006, Increasing rates of influenza vaccination during pregnancy: a multisite interventional study., J Am Board Fam Med, 19, 345, 10.3122/jabfm.19.4.345

Moniz, 2013, Improving influenza vaccination rates in pregnancy through text messaging: a randomized controlled trial., Obstet Gynecol, 121, 734, 10.1097/AOG.0b013e31828642b1

Wong, 2016, Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: a systematic review., Vaccine, 34, 20, 10.1016/j.vaccine.2015.11.020

O’Leary, 2016, Evidence-based vaccination strategies in obstetrics and gynecology settings: Current practices and methods for assessment., Hum Vaccin Immunother, 12, 866, 10.1080/21645515.2015.1130194

Chamberlain, 2015, Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season., Vaccine, 33, 3571, 10.1016/j.vaccine.2015.05.048

Sherman, 2012, Improving influenza vaccination rates in pregnant women., J Reprod Med, 57, 371

Thomas, 2014, Interventions to increase influenza vaccination rates of those 60 years and older in the community., Cochrane Database Syst Rev, CD005188, 10.1002/14651858.CD005188.pub3

Lu, 2014, National and state-specific estimates of place of influenza vaccination among adult populations—United States, 2011–12 influenza season., Vaccine, 32, 3198, 10.1016/j.vaccine.2014.04.003

Goad, 2013, Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience., Ann Fam Med, 11, 429, 10.1370/afm.1542

MacDougall, 2016, Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers., Hum Vaccin Immunother, 12, 623, 10.1080/21645515.2015.1093714

Willis, 2005, Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services., MMWR Recomm Rep, 54, 1

Rolnick SJ, Parker ED, Nordin JD, Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine 2013;31:3928–35. 10.1016/j.vaccine.2013.06.041

Mac Donald, 1999, Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients., Am J Prev Med, 16, 173, 10.1016/S0749-3797(98)00159-7

Mangtani, 2007, Validation of influenza and pneumococcal vaccine status in adults based on self-report., Epidemiol Infect, 135, 139, 10.1017/S0950268806006479

Zimmerman, 2003, Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata., Vaccine, 21, 1486, 10.1016/S0264-410X(02)00700-4

Poland, 2003, Standards for adult immunization practices., Am J Prev Med, 25, 144, 10.1016/S0749-3797(03)00120-X

Lu, 2009, Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors., Vaccine, 27, 882, 10.1016/j.vaccine.2008.11.077

CDC, 2012, Influenza vaccination among pregnant women, the 2011–12 season., MMWR Morb Mortal Wkly Rep, 61, 758

CDC, 2012, Influenza vaccination coverage among health-care personnel—the 2011–12 season., MMWR Morb Mortal Wkly Rep, 61, 753